A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus
- Status
- UNKNOWN
- Phase
- NA
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Impact on Sensitivity and Motor Block Duration of an Intravenous Dexamethasone an Axillary Block With Mepivacaine.
- Status
- COMPLETED
- Phase
- PHASE3
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effect of Preoperative Intravenous Dexamethasone on Postoperative Pain After Primary Total Hip Arthroplasty
- Status
- UNKNOWN
- Phase
- PHASE4
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Effect of Lidocaine/Dexamethasone on the Success of IANB
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Block Duration After Spinal Block and iv Dexamethasone.
- Status
- COMPLETED
- Phase
- PHASE4
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
- Status
- TERMINATED
- Phase
- PHASE2
Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dexamethasone Twice for Pain Treatment of Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE4